Roger Esteban-Fabró

, Spain


Presentations

Cabozantinib enhances the efficacy and immune modulatory activity of anti-PD1 therapy in a syngeneic mouse model of hepatocellular carcinoma 27 August 2020 12:00 - 12:15 More ...